Dr Cho obtained his medical degree from the National University of Singapore and Masters of Medicine (MMed) and Membership of the Royal College of Physicians (MRCP) in 2013. He underwent further training in Rheumatology at the National University Hospital and was accredited as a specialist in Rheumatology in 2018. He completed an additional Masters in Clinical Investigation at the National University of Singapore in 2021.
Dr Cho special interest is in systemic lupus erythematosus (SLE). He is a member of the Asia Pacific Lupus Association, a multinational organisation of experts in systemic lupus erythematosus (SLE) that has described the Lupus Low Disease Activity State (www.asiapacificlupus.com). Dr Cho leads several clinical services, including the quaternary lupus clinic, and the clinic of obstetric rheumatology that manages pregnancy and fertility issues in patients with rheumatic diseases. Dr Cho has also initiated and led Advance Care Planning in Rheumatology; a service directed to ensure that clinical care is aligned with patients’ hopes and wishes. He is also trained in musculoskeletal ultrasound and has obtained the basic and intermediate certificates of competence from the European Union League Against Rheumatism (EULAR). Dr Cho is also trained in Allergy and Immunology that encompass assessment and treatment of patients with food and drug allergies and immunodeficiencies.
Dr Cho is the lead author of research and scientific papers that have been published in top international peer-reviewed journals such as the Journal of American Medical Association (JAMA), Arthritis and Rheumatology, Rheumatology (Oxford) and Seminars in Arthritis and Rheumatism. Dr Cho is a reviewer for Annals of Internal Medicine, Rheumatology (Oxford) and International Journal of Rheumatic Diseases. He has extensive experience in conducting clinical trials in rheumatic conditions, including SLE and inflammatory arthritides, and is the Principal Investigator if Ianalumab phase III trial for SLE patients in NUH.
